# Executable Computational Workflows: Literal Content from Enhanced Papers

This document contains the literal, executable computational workflows from the foundational enhanced papers in each research domain. Each workflow follows a sequential pipeline where the output of one step becomes the input for the next step.

---

## Table of Contents

1. [BGC - Machine Learning Bioactivity Prediction](#bgc---machine-learning-bioactivity-prediction)
2. [Catalysis - Allosteric Effectors for Drug Design](#catalysis---allosteric-effectors-for-drug-design)
3. [Protein Engineering Ecology - Directed Evolution](#protein-engineering-ecology---directed-evolution)
4. [Protein Engineering Expression - Deep Mutational Scanning](#protein-engineering-expression---deep-mutational-scanning)
5. [Regulation - Modular Biosensors](#regulation---modular-biosensors)
6. [RiPP - Discovery and Engineering](#ripp---discovery-and-engineering)

---

# BGC - Machine Learning Bioactivity Prediction

# Workflow 1: Machine Learning Bioactivity Prediction from BGC Sequences

**Paper**: "A machine learning bioinformatics method to predict biological activity from biosynthetic gene clusters"

## Research Objective

- Develop ML method to predict natural product bioactivity from BGC sequences
- Address bioactivity prioritization bottleneck in drug discovery pipeline
- Enable prediction of desired biological functions without production

## Computational Workflow

### STEP 1: BGC Characterization

**INPUT**: 
- BGC sequences from antiSMASH database
- Known bioactivity data for training set (147,000+ BGCs available)
- Genomic context information

**PROCESS**:
- Feature extraction from BGC sequences
- Identification of biosynthetic enzyme types (PKS, NRPS, RiPP, etc.)
- Domain architecture analysis
- Similarity comparison to known BGCs
- Statistical correlation with bioactivities

**OUTPUT**: 
- Feature vectors representing BGC biosynthetic profiles
- Training dataset preparation
- Feature importance assessment
- **Feeds into**: ML model training

---

### STEP 2: Machine Learning Model Development

**INPUT**: 
- Feature vectors and bioactivity labels from Step 1
- Multiple bioactivity categories (antibiotic, antitumor, antifungal, etc.)

**PROCESS**:
- Training on labeled bioactivity dataset
- Feature importance analysis
- Model validation on hold-out test set
- Cross-validation for robustness
- Hyperparameter optimization

**OUTPUT**: 
- Trained ML model for bioactivity prediction
- Model performance metrics
- Feature importance rankings
- **Feeds into**: Large-scale screening

---

### STEP 3: Genome-Wide Bioactivity Prediction

**INPUT**: 
- Trained ML model from Step 2
- 147,000+ identified BGC sequences

**PROCESS**:
- Screen all identified BGCs
- Predict multiple bioactivity types per BGC
- Generate confidence scores
- Prioritize novel scaffolds for experimental validation
- Identify high-priority targets

**OUTPUT**: 
- Ranked prioritization list of BGCs by predicted bioactivity
- Confidence scores for each prediction
- Novel scaffold identification
- **Feeds into**: Experimental prioritization and BGC activation

---

### STEP 4: Experimental Validation Design

**INPUT**: 
- Priority BGCs from Step 3
- Target bioactivity functions

**PROCESS**:
- Selection of BGCs for experimental testing
- BGC activation strategy planning
- Production optimization specifications
- Bioactivity assay design

**OUTPUT**: 
- Experimentally validated bioactive compounds from priority BGCs
- Improved drug discovery pipeline efficiency
- Validated ML predictions for future iterations

---

## Final Experimental Product

**Prioritized bioactive compounds** with:
- Predicted bioactivities from BGC sequences
- Experimentally confirmed bioactivity

---

# Catalysis - Allosteric Effectors for Drug Design

# Workflow 1: Allosteric Effectors for Drug Design

**Paper**: "Toward the design of allosteric effectors: gaining comprehensive control of drug properties and actions"

## Research Objective

- Design allosteric effectors with comprehensive control of drug properties (potency, selectivity, efficacy, safety)
- Demonstrate advantages over orthosteric inhibition through structure-based design

## Computational Workflow

### STEP 1: Allosteric Site Discovery

**INPUT**: 
- Protein target structure (X-ray crystallography or AlphaFold prediction)
- 3D coordinates of active site and potential allosteric sites

**PROCESS**:
- Computational scanning for druggable pockets distant from orthosteric site
- Identification of allosteric communication pathways via normal mode analysis
- Molecular dynamics simulations exploring conformational states

**OUTPUT**: 
- List of candidate allosteric sites with predicted binding regions
- **Feeds into**: Structure-based modulator design

---

### STEP 2: Modulator Optimization

**INPUT**: 
- Candidate allosteric sites from Step 1
- Known bioactive reference compounds (optional)

**PROCESS**:
- Virtual screening against identified allosteric sites
- Multi-property optimization (potency, selectivity, ADMET)
- Iterative docking and scoring calculations
- Property prediction through computational models

**OUTPUT**: 
- Optimized small molecule candidates with predicted properties
- Binding affinity predictions
- ADMET property profiles
- **Feeds into**: Mechanism elucidation

---

### STEP 3: Mechanism Elucidation

**INPUT**: 
- Top candidate modulators from Step 2
- Full protein structure with target binding modes

**PROCESS**:
- MD simulations of ligand-protein complexes
- Free energy calculations of allosteric pathways
- Binding thermodynamics prediction
- Analysis of allosteric communication mechanisms

**OUTPUT**: 
- Validated allosteric modulators with characterized mechanism
- Design principles for future allosteric drug discovery
- Mechanistic insights for selectivity optimization

---

## Final Experimental Product

**Validated allosteric modulators** with:
- Characterized potency and selectivity profiles
- Understood allosteric mechanism
- Design principles transferable to other targets

---

# Protein Engineering Ecology - Directed Evolution

# Workflow 1: Directed Evolution for Protein Function

**Paper**: "Experimental evolution of protein function and specificity"

## Research Objective

- Demonstrate directed evolution capability for improved protein function
- Engineer proteins for biotechnology applications
- Iteratively improve protein properties through selection

## Computational Workflow

### STEP 1: Fitness Landscape Analysis

**INPUT**: 
- Parent protein sequence
- Functional requirement specification
- Target activity/specificity improvements

**PROCESS**:
- Computational prediction of function-altering mutations
- Identification of mutation hotspots
- Constraint analysis for maintaining protein stability
- Structure-function relationship analysis
- Machine learning prediction of beneficial mutations

**OUTPUT**: 
- Designed mutation sites for library construction
- Mutation hotspot prioritization
- **Feeds into**: Directed evolution library design

---

### STEP 2: Directed Evolution Library Design

**INPUT**: 
- Mutation sites from Step 1
- Library size constraints and diversity requirements

**PROCESS**:
- In silico mutagenesis at identified sites
- Diversity optimization of library
- Redundancy management for efficient screening
- Codon optimization for E. coli expression
- Barcode design for variant tracking

**OUTPUT**: 
- Optimized library specification (sequence diversity, size)
- Expression construct design
- **Feeds into**: Screening strategy design

---

### STEP 3: Screening Methodology Design

**INPUT**: 
- Library design from Step 2
- Fitness assay specifications

**PROCESS**:
- Computational selection criteria optimization
- Screen stringency predictions
- Enrichment trajectory modeling
- Positive/negative control design
- Statistical power analysis

**OUTPUT**: 
- Screening protocol specifications
- Expected enrichment rates
- **Feeds into**: Fitness landscape mapping

---

### STEP 4: Fitness Landscape Mapping from Selection Results

**INPUT**: 
- Selection results
- Enriched variant sequences

**PROCESS**:
- Analysis of enriched variants and fitness effects
- Identification of functional mutations
- Epistasis pattern recognition
- Fitness landscape reconstruction
- Mechanistic understanding of beneficial mutations

**OUTPUT**: 
- Engineered protein with improved target function
- Fitness landscape knowledge for rational design
- Design principles for future engineering

---

## Final Experimental Product

**Engineered proteins** with:
- Improved target function and specificity
- Characterized fitness landscape
- Validated for biotechnology applications
- Design principles for iterative improvement

---

# Protein Engineering Expression - Deep Mutational Scanning

# Workflow 1: Deep Mutational Scanning and Enzyme Fitness Trade-offs

**Paper**: "Trade-offs between enzyme fitness and solubility illuminated by deep mutational scanning"

## Research Objective

- Characterize trade-offs between protein solubility and catalytic activity
- Develop predictive models for solubility-enhancing mutations maintaining fitness
- Identify design principles for improving enzyme stability without sacrificing activity

## Computational Workflow

### STEP 1: Deep Mutational Scanning Library Design

**INPUT**: 
- Target enzyme sequence (e.g., TEM-1 beta-lactamase, levoglucosan kinase)
- Target active sites and functional regions

**PROCESS**:
- In silico design of comprehensive mutation library
- Coverage of ~95% of possible single amino acid substitutions
- Redundant barcode design for variant tracking
- Site selection for maximal functional diversity
- Quality control specifications

**OUTPUT**: 
- Complete single-mutation library specification
- Barcode sequences and variant mapping
- **Feeds into**: Selection system design

---

### STEP 2: Dual Selection System Design

**INPUT**: 
- Mutation library from Step 1
- Selection criteria (solubility, fitness)

**PROCESS**:
- Solubility selection method: Yeast surface display (YSD) specification
- Fitness selection method: Twin-arginine translocation (Tat) pathway setup
- Dual-readout optimization
- Selection stringency parameters
- Enrichment threshold calculation

**OUTPUT**: 
- Experimental selection system specifications
- Expected enrichment curves
- **Feeds into**: Fitness landscape analysis

---

### STEP 3: Deep Mutational Scanning Data Analysis

**INPUT**: 
- Selection results from dual screens
- Deep sequencing data (input and output libraries)

**PROCESS**:
- Computational processing of deep sequencing data
- Barcode count normalization
- Fitness score calculation for each variant
- Solubility index determination
- Statistical significance assessment

**OUTPUT**: 
- Complete fitness and solubility landscape for all mutations
- Correlation analysis between properties
- **Feeds into**: Predictive modeling

---

### STEP 4: Predictive Model Development

**INPUT**: 
- Fitness landscape from Step 3
- Structural and evolutionary features

**PROCESS**:
- Identification of sequence features predicting solubility enhancement
- Correlation analysis:
  - Conservation level
  - Distance to active site
  - Contact number
  - Structural position
- Machine learning model training (target: 90% accuracy)
- Cross-validation for robustness

**OUTPUT**: 
- Predictive models for solubility-fitness trade-offs
- Feature importance rankings
- **Feeds into**: Design strategy implementation

---

### STEP 5: Design Strategy Implementation

**INPUT**: 
- Predictive models from Step 4
- Design specifications

**PROCESS**:
- "Back-to-consensus" strategy identification
- Selection of high-fitness, high-solubility mutations
- Multi-mutation combinations design
- Structural validation via X-ray crystallography
- Experimental validation of predictions

**OUTPUT**: 
- Improved enzyme variants with better solubility and retained activity
- Generalizable design principles for stability-activity optimization
- Validated predictions

---

## Final Experimental Product

**Optimized enzymes** with:
- Improved solubility without activity loss
- Characterized trade-off landscape
- Validated design rules
- Production optimization for biotechnology

---

# Regulation - Modular Biosensors

# Workflow 1: Engineering Modular Biosensors for Metabolite-Responsive Regulation

**Paper**: "Engineering Modular Biosensors to Confer Metabolite-Responsive Regulation of Transcription"

## Research Objective

- Develop generalizable approach for engineering novel metabolite-responsive biosensors
- Create modular components for feedback control of metabolic pathways
- Establish foundation for diverse metabolite biosensor applications

## Computational Workflow

### STEP 1: Modular Component Selection

**INPUT**: 
- Target metabolite (e.g., maltose)
- Available ligand-binding protein database (e.g., maltose binding protein - MBP)
- DNA-binding domain library (e.g., zinc finger proteins - ZFP)

**PROCESS**:
- Screening of ligand-binding proteins for target specificity
- Evaluation of DNA-binding domain libraries
- Compatibility assessment through structural analysis
- Binding affinity prediction and validation

**OUTPUT**: 
- Selected modular components (MBP, ZFP candidates)
- Compatibility scores between components
- **Feeds into**: Fusion protein design

---

### STEP 2: Fusion Protein Design

**INPUT**: 
- Selected components from Step 1
- Linker length and composition specifications

**PROCESS**:
- Linker design and optimization for functional coupling
- Computational screening of linker sequences
- Conformational modeling of fusion constructs
- Prediction of allosteric coupling efficiency

**OUTPUT**: 
- Library of MBP-ZFP fusion designs with linker variations
- Predicted conformational states
- Coupling efficiency predictions
- **Feeds into**: Synthetic promoter pairing

---

### STEP 3: Synthetic Promoter Optimization

**INPUT**: 
- Biosensor fusion constructs from Step 2
- Desired output range and dynamics

**PROCESS**:
- Design promoter library with variable operator sequences
- Computational prediction of binding site strengths
- Activity level optimization for biosensor dynamics
- Kinetic parameter prediction (KD, Vmax)

**OUTPUT**: 
- Paired biosensor and promoter designs
- Predicted dose-response curves
- Operator sequence specifications
- **Feeds into**: High-throughput screening design

---

### STEP 4: High-Throughput Screening Design

**INPUT**: 
- Biosensor-promoter pairs from Step 3
- Target performance criteria

**PROCESS**:
- Library construction specifications
- Screening methodology optimization
- Data analysis pipeline for variant selection
- Statistical analysis plan for hit identification

**OUTPUT**: 
- HTS protocol specifications
- Validated metabolite biosensors with design principles
- Generalizable framework for other metabolites

---

## Final Experimental Product

**Validated metabolite biosensors** with:
- Characterized metabolite specificity
- Tunable output ranges
- Design principles transferable to other metabolites
- Functional regulatory circuits for metabolic engineering

---

# RiPP - Discovery and Engineering

# Workflow 1: Discovery and Engineering of RiPP Natural Products

**Paper**: "Discovery and engineering of ribosomally synthesized and post-translationally modified peptide (RiPP) natural products"

## Research Objective

- Comprehensive review of RiPP discovery using bioactivity-guided screening, genome mining, and biosynthetic engineering
- Develop strategies for activating silent RiPP clusters
- Enable systematic access to diverse RiPP natural products

## Computational Workflow

### STEP 1: RiPP Bioactivity-Guided Screening

**INPUT**: 
- Microbial genomic sequences + bioactivity screening data
- Microbial sample collection data from diverse environments

**PROCESS**:
- High-throughput screening data analysis (HiTES - high-throughput elicitor screening)
- LAESI-IMS (laser ablation electrospray ionization mass spectrometry) data processing
- MS-based dereplication against known compounds
- Identification of novel bioactive molecules
- Environmental source characterization

**OUTPUT**: 
- Identified bioactive RiPP candidates from screening
- Chemical characterization and novelty assessment
- Source organism identification
- **Feeds into**: Genome mining correlation

---

### STEP 2: RiPP Genome Mining

**INPUT**: 
- Bioactivity-identified RiPPs from Step 1
- Genomic sequences from bioactive sources
- RiPP database and classification information

**PROCESS**:
- Precursor peptide sequence identification (BLAST, machine learning tools)
- PTM enzyme detection using tools: RODEO, RiPPER, RRE-Finder
- BGC boundary prediction and classification
- RiPP class assignment
- Correlation of genomic finding with bioactivity

**OUTPUT**: 
- Computationally identified RiPP BGCs correlated with bioactivity
- PTM enzyme characterization
- Precursor peptide sequences
- **Feeds into**: Silent cluster activation strategy

---

### STEP 3: Silent RiPP Activation Design

**INPUT**: 
- Characterized RiPP BGCs from Step 2
- Known RiPPs and their expression strategies

**PROCESS**:
- Computational design of BGC expression constructs
- Regulatory element engineering strategy
- Heterologous host selection and optimization
- Activation signal design (if needed)
- Expression system optimization

**OUTPUT**: 
- Expression system specifications for RiPP production
- Optimized construct designs
- Host strain specifications
- **Feeds into**: Biosynthetic engineering

---

### STEP 4: Biosynthetic Engineering and PTM Optimization

**INPUT**: 
- RiPP expression systems from Step 3
- PTM pathway information

**PROCESS**:
- Precursor peptide engineering for improved PTM efficiency
- Enzyme expression level optimization
- PTM pathway engineering
- Post-modification validation
- Yield optimization

**OUTPUT**: 
- Engineered RiPP production system with optimized yield
- Characterized RiPP products
- Production optimization parameters

---

## Final Experimental Product

**Engineered RiPP production** with:
- Novel RiPPs successfully produced from silent clusters
- Characterized bioactivity
- Scalable production systems
- Ready for therapeutic development
- **INPUT SOURCE:** Trained ML models from Step 3 + new sequencing data from diverse organisms
- **PROCESS:**
  - Apply ML models to new sequencing data
  - Identify unconventional or cryptic clusters
  - Predict orphan products and score candidates
- **EXECUTABLE OUTPUT:** Discovery of novel BGCs and predicted products + prioritized candidates for activation

---

## Workflow 3: Silent BGC Activation in Streptomyces

**Research Objective:** Activate and produce from 90% of silent BGCs in Streptomyces genomes

### STEP 1: BGC Reconstruction Design
**ACTION:** Computationally design BGC reconstruction strategy
- **INPUT SOURCE:** Streptomyces genome + identified silent BGCs
- **PROCESS:**
  - Assess pathway completeness
  - Identify regulatory elements
  - Design segment sizing for cloning
- **EXECUTABLE OUTPUT:** BGC reconstruction specifications + assembly method selection + cloning strategy
- **NEXT STEP INPUT:** Use specifications for heterologous host selection

### STEP 2: Heterologous Host Selection and Optimization
**ACTION:** Computationally predict optimal heterologous hosts
- **INPUT SOURCE:** BGC reconstruction specs from Step 1 + heterologous host database
- **PROCESS:**
  - Assess compatible hosts (Streptomyces, actinobacteria, Bacillus, fungi)
  - Predict metabolic compatibility
  - Design chassis engineering strategy
- **EXECUTABLE OUTPUT:** Optimized heterologous host + chassis engineering specifications + metabolic capacity predictions
- **NEXT STEP INPUT:** Design regulatory elements for selected host

### STEP 3: Regulatory Element Engineering
**ACTION:** Optimize expression cassettes for heterologous host
- **INPUT SOURCE:** Heterologous host specs from Step 2 + BGC regulatory sequences
- **PROCESS:**
  - Predict promoter strength
  - Optimize ribosome binding sites (RBS)
  - Design expression cassette assembly
- **EXECUTABLE OUTPUT:** Enhanced regulatory element specifications + optimized expression cassettes
- **NEXT STEP INPUT:** Predict expression levels in new system

### STEP 4: Expression Level Prediction and Activation
**ACTION:** Predict and validate BGC activation in heterologous host
- **INPUT SOURCE:** Regulatory elements from Step 3 + BGC gene information
- **PROCESS:**
  - Model BGC expression in heterologous host
  - Predict metabolite production levels
  - Identify optimization bottlenecks
- **EXECUTABLE OUTPUT:** Activated BGC system with predicted metabolite yields

---

## Workflow 4: High-Throughput Discovery of Silent Cluster Elicitors

**Research Objective:** Systematically discover small molecule activators of silent bacterial gene clusters

### STEP 1: Elicitor Library Design
**ACTION:** Design diverse library of potential BGC activators
- **INPUT SOURCE:** Silent BGC information + known elicitor molecules + target activation phenotype
- **PROCESS:**
  - Perform computational diversity analysis
  - Optimize structural features for activation potential
  - Calculate diversity metrics
- **EXECUTABLE OUTPUT:** Designed diverse elicitor small molecule library + library specifications
- **NEXT STEP INPUT:** Design HTS assay for screening

### STEP 2: HTS Plate and Data Analysis Pipeline Design
**ACTION:** Design high-throughput screening protocol and analysis
- **INPUT SOURCE:** Elicitor library from Step 1 + silent cluster specifications
- **PROCESS:**
  - Optimize experimental design
  - Define statistical analysis methods
  - Set hit selection criteria
- **EXECUTABLE OUTPUT:** HTS protocol specifications + data analysis pipeline + statistical thresholds
- **NEXT STEP INPUT:** Execute screening experiments

### STEP 3: Screening Data Analysis
**ACTION:** Process and analyze HTS screening results
- **INPUT SOURCE:** HTS screening results from wet lab
- **PROCESS:**
  - Normalize and assess data quality
  - Identify and rank hits
  - Perform dose-response analysis
- **EXECUTABLE OUTPUT:** Identified elicitors ranked by activation strength + dose-response characteristics
- **NEXT STEP INPUT:** Validate with metabolite identification

### STEP 4: Metabolite Identification from Activated Clusters
**ACTION:** Identify novel compounds produced by activated clusters
- **INPUT SOURCE:** Activated cultures with confirmed elicitors + MS/NMR capabilities
- **PROCESS:**
  - Analyze differential metabolomics data
  - Extract and annotate MS features
  - Perform structural elucidation
- **EXECUTABLE OUTPUT:** Identified elicitors + novel bioactive compounds from previously inaccessible BGCs

---

## Workflow 5: Genomics-Driven Discovery of Microbial Natural Products

**Research Objective:** Leverage genome mining to discover novel natural product scaffolds and overcome antibiotic resistance

### STEP 1: BGC Mining and Prioritization
**ACTION:** Mine genomes and prioritize novel BGCs
- **INPUT SOURCE:** Microbial genomic sequences + drug-resistance information
- **PROCESS:**
  - Identify and annotate BGCs computationally
  - Assess structural novelty
  - Analyze scaffold diversity
- **EXECUTABLE OUTPUT:** Prioritized list of novel BGCs + novelty scores
- **NEXT STEP INPUT:** Select expression strategy for priority BGCs

### STEP 2: Expression Strategy Selection
**ACTION:** Choose optimal expression approach for each BGC
- **INPUT SOURCE:** Priority BGCs from Step 1 + available expression systems
- **PROCESS:**
  - Evaluate heterologous vs. native expression
  - Predict host compatibility
  - Analyze metabolic pathway requirements
- **EXECUTABLE OUTPUT:** Selected expression approach + host system specifications
- **NEXT STEP INPUT:** Design pathway engineering modifications

### STEP 3: Pathway Engineering for Production Optimization
**ACTION:** Computationally optimize metabolic pathways for production
- **INPUT SOURCE:** Expression system from Step 2 + BGC structural information
- **PROCESS:**
  - Model rate-limiting steps
  - Optimize enzyme expression levels
  - Assess precursor availability
  - Perform metabolic flux analysis
- **EXECUTABLE OUTPUT:** Optimized pathway engineering specifications + production level improvements
- **NEXT STEP INPUT:** Design regulatory modifications

### STEP 4: Global Regulatory Manipulation Strategy
**ACTION:** Design regulatory changes to boost production
- **INPUT SOURCE:** Optimized pathway from Step 3 + target production levels
- **PROCESS:**
  - Computationally design regulatory modifications
  - Model pleiotropic effects
  - Optimize co-culture parameters
  - Model environmental induction strategies
- **EXECUTABLE OUTPUT:** Regulatory modification specifications + optimized environmental conditions
- **NEXT STEP INPUT:** Test production and bioactivity

### STEP 5: Bioactivity Assessment and Drug Development
**ACTION:** Screen produced compounds and assess therapeutic potential
- **INPUT SOURCE:** Produced compounds from optimized system
- **PROCESS:**
  - Perform high-throughput bioactivity screening
  - Predict mechanism of action
  - Analyze structure-activity relationships
- **EXECUTABLE OUTPUT:** Novel bioactive compounds with improved production + development recommendations

---

# Catalysis - Enzyme and Allosteric Design

## Workflow 1: Allosteric Effectors for Drug Design

**Research Objective:** Design allosteric effectors with comprehensive control of drug properties

### STEP 1: Allosteric Site Discovery
**ACTION:** Identify druggable allosteric sites on protein targets
- **INPUT SOURCE:** Protein target structure (X-ray or AlphaFold) + active site information
- **PROCESS:**
  - Computationally scan for allosteric pockets
  - Identify communication pathways via normal mode analysis
  - Perform MD simulations of conformational states
- **EXECUTABLE OUTPUT:** Candidate allosteric sites with predicted binding regions
- **NEXT STEP INPUT:** Design modulators for identified sites

### STEP 2: Modulator Optimization
**ACTION:** Design and optimize small molecule allosteric modulators
- **INPUT SOURCE:** Candidate allosteric sites from Step 1 + known bioactive compounds
- **PROCESS:**
  - Perform virtual screening against identified sites
  - Optimize potency, selectivity, ADMET properties
  - Calculate binding affinities
- **EXECUTABLE OUTPUT:** Optimized small molecule candidates + binding affinity predictions + ADMET profiles
- **NEXT STEP INPUT:** Characterize mechanism of action

### STEP 3: Mechanism Elucidation
**ACTION:** Characterize allosteric mechanism and communication pathways
- **INPUT SOURCE:** Top candidate modulators from Step 2 + full protein structure
- **PROCESS:**
  - Run MD simulations of ligand-protein complexes
  - Calculate free energy of allosteric pathways
  - Analyze allosteric communication
- **EXECUTABLE OUTPUT:** Validated allosteric modulators with characterized mechanisms

---

## Workflow 2: AlphaFold2 for Enzyme Conformational Flexibility

**Research Objective:** Use AF2 to generate conformations and design enzymes with improved catalysis

### STEP 1: Conformational Ensemble Generation
**ACTION:** Generate diverse conformations from enzyme sequence
- **INPUT SOURCE:** Enzyme sequence (FASTA) + multiple sequence alignment (MSA)
- **PROCESS:**
  - Apply AlphaFold2 with MSA depth variation
  - Apply position masking and clustering
  - Generate 50-100+ diverse conformations
  - Rank by pAE confidence scores
- **EXECUTABLE OUTPUT:** Conformational ensemble + pAE confidence scores
- **NEXT STEP INPUT:** Construct free energy landscape

### STEP 2: Free Energy Landscape (FEL) Analysis
**ACTION:** Reconstruct conformational energy landscape
- **INPUT SOURCE:** Conformational ensemble from Step 1 + phenotype/activity data
- **PROCESS:**
  - Project conformations onto collective degrees of freedom
  - Calculate relative stabilities and kinetic barriers
  - Identify catalytically relevant conformational changes
- **EXECUTABLE OUTPUT:** Free energy landscape showing conformational pathways + major states + kinetic barriers
- **NEXT STEP INPUT:** Design mutations targeting conformational optimization

### STEP 3: Design-Informed Mutations
**ACTION:** Predict mutations to improve conformational landscape for catalysis
- **INPUT SOURCE:** Free energy landscape from Step 2 + catalytic cycle knowledge
- **PROCESS:**
  - Predict mutations affecting conformational entropy
  - Model improved substrate binding geometries
  - Evaluate conformational transition improvements
- **EXECUTABLE OUTPUT:** Design specifications for enzyme variants + mutation predictions
- **NEXT STEP INPUT:** Validate designed variants experimentally

### STEP 4: Experimental Validation Design
**ACTION:** Plan experimental validation of designed variants
- **INPUT SOURCE:** Proposed mutations from Step 3
- **PROCESS:**
  - Specify X-ray crystallography with B-factor analysis
  - Plan room-temperature X-ray experiments
  - Design NMR spectroscopy validation
- **EXECUTABLE OUTPUT:** Computationally designed enzyme variants with improved catalytic efficiency

---

## Workflow 3: Allosteric Landscapes - Computational Methodologies

**Research Objective:** Develop computational pipeline for systematic allosteric modulator discovery

### STEP 1: Allosteric Site Prediction
**ACTION:** Computationally predict druggable allosteric sites
- **INPUT SOURCE:** Protein structure + ligand-binding data + known allosteric sites (if available)
- **PROCESS:**
  - Use PASSer tool for allosteric site prediction
  - Perform normal mode analysis
  - Map evolutionary conservation
- **EXECUTABLE OUTPUT:** Predicted allosteric sites ranked by druggability
- **NEXT STEP INPUT:** Characterize allosteric mechanisms

### STEP 2: Allosteric Mechanism Characterization
**ACTION:** Characterize conformational and dynamic modes of allosteric sites
- **INPUT SOURCE:** Candidate allosteric sites from Step 1 + protein dynamics data
- **PROCESS:**
  - Run MD simulations of ligand-bound and apo states
  - Apply enhanced sampling (replica exchange, metadynamics)
  - Use AlloReverse for mechanism classification
- **EXECUTABLE OUTPUT:** Characterized allosteric mechanisms + thermodynamic and kinetic information
- **NEXT STEP INPUT:** Train ML models for modulator prediction

### STEP 3: Machine Learning Modulator Discovery
**ACTION:** Use ML to identify novel allosteric modulators
- **INPUT SOURCE:** Characterized mechanisms from Step 2 + known modulators database + chemical libraries
- **PROCESS:**
  - Train ML models on known allosteric modulators
  - Perform virtual screening with ML predictions
  - Predict activity and selectivity
- **EXECUTABLE OUTPUT:** Ranked library of predicted modulators + confidence scores
- **NEXT STEP INPUT:** Validate top candidates experimentally

### STEP 4: Systematic Discovery Framework
**ACTION:** Implement full discovery pipeline
- **INPUT SOURCE:** Predicted modulators from Step 3 + target criteria
- **PROCESS:**
  - Rank and filter candidates
  - Optimize multi-properties
  - Predict toxicity and ADMET
- **EXECUTABLE OUTPUT:** Validated allosteric modulators ready for development

---

## Workflow 4: Artificial Allosteric Protein Switches

**Research Objective:** Engineer programmable allosteric protein systems using ML-designed receptors

### STEP 1: ML-Designed Receptor Domain
**ACTION:** Design minimal ligand-binding domain using machine learning
- **INPUT SOURCE:** Target ligand molecule + binding affinity specifications + sequence/structure constraints
- **PROCESS:**
  - Train generative ML model on known binders
  - Design minimal ligand-binding domain scaffolds
  - Predict specificity and binding affinity
  - Ensure compatibility with allosteric coupling
- **EXECUTABLE OUTPUT:** ML-designed receptor domain sequences + binding predictions + entropy signatures
- **NEXT STEP INPUT:** Optimize linker and reporter components

### STEP 2: Linker and Reporter Domain Optimization
**ACTION:** Design connecting linker and select reporter enzyme
- **INPUT SOURCE:** Receptor domain from Step 1 + desired output modality (colorimetric, fluorescent, enzymatic)
- **PROCESS:**
  - Design connecting linkers computationally
  - Select compatible reporter enzymes/proteins
  - Optimize linker rigidity/flexibility
- **EXECUTABLE OUTPUT:** Full biosensor construct design + linker sequences + reporter specifications
- **NEXT STEP INPUT:** Analyze conformational changes

### STEP 3: Conformational Analysis
**ACTION:** Model conformational changes in complete biosensor
- **INPUT SOURCE:** Complete biosensor construct from Step 2 + target ligand
- **PROCESS:**
  - Run MD simulations of apo and ligand-bound states
  - Predict conformational entropy changes
  - Model allosteric communication
  - Quantify H/D exchange patterns
- **EXECUTABLE OUTPUT:** Predicted conformational changes + entropy quantification
- **NEXT STEP INPUT:** Design logic gates if needed

### STEP 4: Logic Gate Design
**ACTION:** Design multi-input biosensor systems
- **INPUT SOURCE:** Validated biosensor designs from Step 3 + multiple ligand specifications
- **PROCESS:**
  - Design YES and AND logic gates computationally
  - Optimize allosteric communication
  - Minimize cross-talk
- **EXECUTABLE OUTPUT:** Logic circuit designs for cellular applications + dose-response curves

---

## Workflow 5: Addressing Epistasis in Protein Design

**Research Objective:** Develop methods to predict epistasis and improve protein design accuracy

### STEP 1: Fitness Landscape Mapping
**ACTION:** Map epistatic interactions between mutations
- **INPUT SOURCE:** Protein sequence data + functional constraints + target phenotype
- **PROCESS:**
  - Simulate deep mutational scanning
  - Assess epistatic interactions between mutations
  - Collect single and multi-mutation fitness effects
- **EXECUTABLE OUTPUT:** Comprehensive epistasis interaction map + fitness values for combinations
- **NEXT STEP INPUT:** Quantify epistasis patterns

### STEP 2: Epistasis Quantification and Pattern Recognition
**ACTION:** Analyze and classify epistatic interaction types
- **INPUT SOURCE:** Fitness landscape from Step 1 + structural context
- **PROCESS:**
  - Quantify deviation from additivity
  - Apply ML for epistasis pattern recognition
  - Correlate with structural features
- **EXECUTABLE OUTPUT:** Epistasis models + interaction type classification + mechanistic insights
- **NEXT STEP INPUT:** Improve protein design using epistasis

### STEP 3: Epistasis-Aware Design Optimization
**ACTION:** Integrate epistatic constraints into design algorithms
- **INPUT SOURCE:** Epistasis models from Step 2 + design objectives
- **PROCESS:**
  - Incorporate epistatic constraints in design
  - Predict variant combinations with high fitness
  - Identify synergistic effects
- **EXECUTABLE OUTPUT:** Epistasis-optimized protein designs + design principles
- **NEXT STEP INPUT:** Extract generalizable design rules

### STEP 4: Design Principle Extraction
**ACTION:** Generate transferable design rules from epistasis
- **INPUT SOURCE:** Epistasis-aware designs from Step 3
- **PROCESS:**
  - Extract generalizable design rules
  - Develop predictive models for new targets
  - Apply ML for pattern generalization
- **EXECUTABLE OUTPUT:** Improved protein variants with reduced trial-and-error in directed evolution

---

# Protein Engineering - Ecology

## Workflow 1: Directed Evolution for Protein Function

**Research Objective:** Engineer proteins for improved function through iterative selection

### STEP 1: Fitness Landscape Analysis
**ACTION:** Identify mutation sites that improve protein function
- **INPUT SOURCE:** Parent protein sequence + functional requirements + activity improvements needed
- **PROCESS:**
  - Predict function-altering mutations computationally
  - Identify mutation hotspots
  - Analyze structure-function relationships
  - Apply ML for beneficial mutation prediction
- **EXECUTABLE OUTPUT:** Designed mutation sites + prioritized hotspots for library
- **NEXT STEP INPUT:** Design directed evolution library

### STEP 2: Directed Evolution Library Design
**ACTION:** Design mutation library for screening
- **INPUT SOURCE:** Mutation sites from Step 1 + library size and diversity constraints
- **PROCESS:**
  - Perform in silico mutagenesis at identified sites
  - Optimize library diversity
  - Manage redundancy for efficient screening
  - Optimize codons for E. coli expression
  - Design barcodes for variant tracking
- **EXECUTABLE OUTPUT:** Optimized library specifications + expression construct design
- **NEXT STEP INPUT:** Design screening strategy

### STEP 3: Screening Methodology Design
**ACTION:** Design screening protocol and selection criteria
- **INPUT SOURCE:** Library design from Step 2 + fitness assay specs
- **PROCESS:**
  - Optimize selection criteria
  - Predict enrichment trajectories
  - Design positive/negative controls
  - Perform statistical power analysis
- **EXECUTABLE OUTPUT:** Screening protocol specifications + expected enrichment rates
- **NEXT STEP INPUT:** Analyze selection results

### STEP 4: Fitness Landscape Mapping from Selection Results
**ACTION:** Analyze enriched variants and extract design principles
- **INPUT SOURCE:** Selection results from wet lab experiments
- **PROCESS:**
  - Analyze enriched variants for fitness effects
  - Identify functional mutations
  - Recognize epistasis patterns
  - Reconstruct fitness landscape
- **EXECUTABLE OUTPUT:** Engineered proteins with improved function + transferable design principles

---

## Workflow 2: Enzyme Engineering for Biocatalysis

**Research Objective:** Engineer enzymes with improved catalytic properties for sustainable biotechnology

### STEP 1: Active Site Analysis
**ACTION:** Analyze wild-type enzyme active site
- **INPUT SOURCE:** Wild-type enzyme structure + substrate specs + desired improvements
- **PROCESS:**
  - Analyze active site geometry computationally
  - Predict substrate binding mode
  - Identify rate-limiting steps
  - Analyze cofactor binding
- **EXECUTABLE OUTPUT:** Characterized active site + substrate-enzyme interaction profile
- **NEXT STEP INPUT:** Design active site mutations

### STEP 2: Rational Design of Active Site
**ACTION:** Computationally design active site mutations
- **INPUT SOURCE:** Active site analysis from Step 1 + catalytic mechanism knowledge
- **PROCESS:**
  - Design mutations for improved substrate positioning
  - Optimize catalytic residues
  - Enhance cofactor binding
  - Predict transition state stabilization
- **EXECUTABLE OUTPUT:** Designed enzyme variants + mutation specifications
- **NEXT STEP INPUT:** Optimize expression system

### STEP 3: Expression System Optimization
**ACTION:** Optimize heterologous protein expression
- **INPUT SOURCE:** Designed variants from Step 2 + E. coli expression system
- **PROCESS:**
  - Optimize codons for E. coli
  - Optimize RBS for expression level
  - Predict and enhance solubility
  - Model protein folding
- **EXECUTABLE OUTPUT:** Optimized expression construct + expression level predictions
- **NEXT STEP INPUT:** Analyze enzyme kinetics

### STEP 4: Kinetic Analysis and Optimization
**ACTION:** Characterize and optimize catalytic kinetics
- **INPUT SOURCE:** Expressed enzyme variants
- **PROCESS:**
  - Predict kcat and KM values
  - Calculate specificity constants
  - Compare to wild-type benchmark
  - Optimize catalytic efficiency
- **EXECUTABLE OUTPUT:** Biocatalyst with optimized kinetic properties + industrial scalability

---

## Workflow 3: CRISPR-Cas12a Biosensor Array for DNA Detection

**Research Objective:** Develop highly sensitive, multiplexed DNA detection platform

### STEP 1: gRNA Design and Optimization
**ACTION:** Design guide RNAs for target DNA detection
- **INPUT SOURCE:** Target DNA sequences + detection requirements (SNP, mutations)
- **PROCESS:**
  - Computationally design gRNA sequences for each target
  - Predict and minimize off-targets
  - Optimize gRNA positioning
  - Predict thermodynamic stability
- **EXECUTABLE OUTPUT:** Optimized gRNA sequences + off-target assessment
- **NEXT STEP INPUT:** Design reporter molecules

### STEP 2: Reporter Molecular Design
**ACTION:** Design fluorescent reporter constructs
- **INPUT SOURCE:** gRNA designs from Step 1 + reporter output modality specs
- **PROCESS:**
  - Select fluorescent reporter proteins
  - Optimize quencher pairing
  - Design signal amplification strategy
  - Model reporter expression and kinetics
- **EXECUTABLE OUTPUT:** Reporter construct specifications + signal amplification predictions
- **NEXT STEP INPUT:** Design array multiplexing

### STEP 3: Array Multiplexing Design
**ACTION:** Design multiplexed detection array
- **INPUT SOURCE:** Reporter constructs from Step 2 + multiple target requirements
- **PROCESS:**
  - Optimize layout for simultaneous detection
  - Minimize cross-talk
  - Verify signal independence
- **EXECUTABLE OUTPUT:** Biosensor array design + multiplexing specifications
- **NEXT STEP INPUT:** Model assay performance

### STEP 4: Assay Performance Modeling
**ACTION:** Predict diagnostic performance metrics
- **INPUT SOURCE:** Array design from Step 3 + clinical sample requirements
- **PROCESS:**
  - Predict sensitivity (LoD calculations)
  - Validate specificity
  - Optimize sample processing
  - Model turnaround time
- **EXECUTABLE OUTPUT:** Validated biosensor array with ultrasensitive multiplexed detection

---

## Workflow 4: Plant to Yeast - Biosynthesis of Aromatic Compounds

**Research Objective:** Engineer yeast for production of plant-derived aromatic compounds

### STEP 1: Pathway Analysis and Optimization
**ACTION:** Analyze plant biosynthetic pathway for yeast transfer
- **INPUT SOURCE:** Plant biosynthetic pathway sequences + identified BGCs + target compound specs
- **PROCESS:**
  - Analyze plant pathway enzymes computationally
  - Predict heterologous expression in yeast
  - Identify rate-limiting steps
  - Assess cofactor requirements
- **EXECUTABLE OUTPUT:** Optimized pathway specifications + enzyme prioritization
- **NEXT STEP INPUT:** Engineer enzymes for yeast expression

### STEP 2: Enzyme Engineering for Yeast Expression
**ACTION:** Optimize plant enzymes for S. cerevisiae
- **INPUT SOURCE:** Pathway enzymes from Step 1 + S. cerevisiae expression system
- **PROCESS:**
  - Optimize codons for S. cerevisiae
  - Design localization signals
  - Predict expression levels
  - Enhance protein solubility
- **EXECUTABLE OUTPUT:** Engineered plant enzyme genes optimized for yeast
- **NEXT STEP INPUT:** Design metabolic integration

### STEP 3: Metabolic Pathway Integration
**ACTION:** Integrate heterologous pathway into yeast metabolism
- **INPUT SOURCE:** Engineered enzymes from Step 2 + yeast central metabolism info
- **PROCESS:**
  - Design pathway assembly
  - Assess cofactor availability
  - Perform metabolic flux analysis
  - Identify competition with endogenous pathways
- **EXECUTABLE OUTPUT:** Integrated metabolic pathway specifications
- **NEXT STEP INPUT:** Optimize strain for production

### STEP 4: Strain-Level Optimization
**ACTION:** Engineer yeast strain for maximum aromatic compound production
- **INPUT SOURCE:** Integrated pathway from Step 3 + production target specs
- **PROCESS:**
  - Tune promoter strengths for pathway expression
  - Balance ATP and NADPH availability
  - Mitigate toxicity effects
  - Optimize growth-production trade-off
- **EXECUTABLE OUTPUT:** Engineered yeast strain producing plant aromatic compounds

---

## Workflow 5: Plasmodium Resistance to Artemisinins

**Research Objective:** Understand artemisinin resistance and identify new antimalarial targets

### STEP 1: Target Identification and Resistance Mutation Analysis
**ACTION:** Analyze artemisinin resistance mutations
- **INPUT SOURCE:** Plasmodium genomic sequences from resistant strains + PfATPase6 information
- **PROCESS:**
  - Analyze PfATPase6 mutations in resistant strains
  - Map resistance-associated mutations
  - Predict functional impacts
  - Perform phylogenetic analysis of resistance spread
- **EXECUTABLE OUTPUT:** Characterized resistance mutations + distribution patterns
- **NEXT STEP INPUT:** Analyze artemisinin binding

### STEP 2: Artemisinin Binding Mode Analysis
**ACTION:** Characterize how resistance mutations affect drug binding
- **INPUT SOURCE:** Characterized mutations from Step 1 + ATPase6 structure
- **PROCESS:**
  - Perform molecular docking of artemisinins
  - Predict binding affinity changes from mutations
  - Analyze selectivity vs. human ATPase
- **EXECUTABLE OUTPUT:** Characterized artemisinin-ATPase6 interactions + selectivity profile
- **NEXT STEP INPUT:** Identify alternative targets

### STEP 3: New Antimalarial Target Mining
**ACTION:** Identify and prioritize new drug targets
- **INPUT SOURCE:** Resistance mechanisms from Step 2 + essential genes database
- **PROCESS:**
  - Mine Plasmodium essential genes computationally
  - Assess target druggability
  - Predict specificity vs. human orthologs
- **EXECUTABLE OUTPUT:** Prioritized new antimalarial targets
- **NEXT STEP INPUT:** Design new inhibitors

### STEP 4: New Inhibitor Design
**ACTION:** Design new antimalarial compounds for resistance-independent targets
- **INPUT SOURCE:** Identified targets from Step 3 + target structure/function specs
- **PROCESS:**
  - Perform virtual screening against targets
  - Optimize lead compounds
  - Predict selectivity and toxicity
- **EXECUTABLE OUTPUT:** Next-generation antimalarial compounds overcoming resistance

---

# Protein Engineering - Expression

## Workflow 1: Deep Mutational Scanning and Enzyme Fitness Trade-offs

**Research Objective:** Characterize trade-offs between protein solubility and catalytic activity

### STEP 1: Deep Mutational Scanning Library Design
**ACTION:** Design comprehensive mutation library covering ~95% of possible substitutions
- **INPUT SOURCE:** Target enzyme sequence (e.g., TEM-1 beta-lactamase) + active sites
- **PROCESS:**
  - Design comprehensive single-mutation library in silico
  - Create redundant barcode design for tracking
  - Select sites for maximal diversity
- **EXECUTABLE OUTPUT:** Complete single-mutation library specification + barcode mapping
- **NEXT STEP INPUT:** Design dual selection system

### STEP 2: Dual Selection System Design
**ACTION:** Design experimental system for dual solubility and fitness screening
- **INPUT SOURCE:** Mutation library from Step 1 + selection criteria
- **PROCESS:**
  - Design solubility selection (yeast surface display)
  - Design fitness selection (Tat pathway)
  - Optimize dual-readout parameters
- **EXECUTABLE OUTPUT:** Selection system specifications + enrichment curve predictions
- **NEXT STEP INPUT:** Analyze screening data

### STEP 3: Deep Mutational Scanning Data Analysis
**ACTION:** Process deep sequencing results to extract fitness landscape
- **INPUT SOURCE:** Selection results from dual screens + deep sequencing data
- **PROCESS:**
  - Process deep sequencing computationally
  - Normalize barcode counts
  - Calculate fitness and solubility scores for all variants
  - Assess statistical significance
- **EXECUTABLE OUTPUT:** Complete fitness and solubility landscape for all mutations
- **NEXT STEP INPUT:** Develop predictive models

### STEP 4: Predictive Model Development
**ACTION:** Build ML models predicting solubility-fitness trade-offs
- **INPUT SOURCE:** Fitness landscape from Step 3 + structural and evolutionary features
- **PROCESS:**
  - Identify sequence features predicting solubility
  - Correlate with structural properties:
    - Conservation level
    - Distance to active site
    - Contact number
  - Train ML models (target 90% accuracy)
- **EXECUTABLE OUTPUT:** Predictive models for trade-offs + feature importance rankings
- **NEXT STEP INPUT:** Implement design strategies

### STEP 5: Design Strategy Implementation
**ACTION:** Design improved enzyme variants using predictions
- **INPUT SOURCE:** Predictive models from Step 4 + design goals
- **PROCESS:**
  - Identify "back-to-consensus" mutations
  - Select high-fitness, high-solubility combinations
  - Design multi-mutation combinations
  - Validate structures via X-ray crystallography
- **EXECUTABLE OUTPUT:** Improved enzyme variants with better solubility and retained activity

---

## Workflow 2: Epistatic Fitness Landscape in Enzyme Active Sites

**Research Objective:** Map comprehensive epistatic interactions in enzyme fitness landscape

### STEP 1: Combinatorial Library Design
**ACTION:** Design library covering all possible combinations for selected residues
- **INPUT SOURCE:** Target enzyme with active site residues + computational budget
- **PROCESS:**
  - Design all possible combinations for selected residues
  - Calculate library feasibility
  - Assign variant encoding and barcodes
  - Validate completeness
- **EXECUTABLE OUTPUT:** Complete combinatorial mutation library specification
- **NEXT STEP INPUT:** Perform high-throughput screening

### STEP 2: High-Throughput Functional Screening
**ACTION:** Screen all variants for activity
- **INPUT SOURCE:** Combinatorial library from Step 1 + activity assay specs
- **PROCESS:**
  - Express library in screening format
  - Select based on target function
  - Perform deep sequencing of selected and input libraries
  - Calculate fitness for every combination
- **EXECUTABLE OUTPUT:** Complete epistatic fitness landscape with all combinations
- **NEXT STEP INPUT:** Quantify epistasis

### STEP 3: Epistasis Quantification
**ACTION:** Calculate and quantify all epistatic interactions
- **INPUT SOURCE:** Fitness values for all combinations from Step 2
- **PROCESS:**
  - Calculate pairwise epistasis (2-way interactions)
  - Analyze higher-order epistasis (3-way, 4-way, etc.)
  - Test statistical significance
  - Quantify effect sizes
- **EXECUTABLE OUTPUT:** Quantified epistasis map with interaction strengths + hierarchical patterns
- **NEXT STEP INPUT:** Perform mechanistic analysis

### STEP 4: Mechanistic Analysis
**ACTION:** Link epistasis patterns to structural and functional mechanisms
- **INPUT SOURCE:** Epistasis quantification from Step 3 + structural information
- **PROCESS:**
  - Correlate epistasis with structural features:
    - Spatial proximity
    - Contact networks
    - Conformational changes
  - Identify mechanistically important interactions
  - Predict evolutionary constraints
- **EXECUTABLE OUTPUT:** Mechanistic understanding of epistasis + structure-function relationships
- **NEXT STEP INPUT:** Extract design rules

### STEP 5: Design Rules Extraction
**ACTION:** Extract and validate design principles from epistasis
- **INPUT SOURCE:** Mechanistic analysis from Step 4 + fitness landscape
- **PROCESS:**
  - Apply ML to extract design principles
  - Predict optimal multi-mutation combinations
  - Test generalizability across enzyme classes
- **EXECUTABLE OUTPUT:** Comprehensive fitness landscape with extracted design rules

---

## Workflow 3: Machine Learning Protein Design

**Research Objective:** Develop ML models for protein property prediction and design

### STEP 1: Feature Engineering
**ACTION:** Extract sequence and structural features for ML
- **INPUT SOURCE:** Protein sequence and structure database + experimental property measurements
- **PROCESS:**
  - Extract sequence features:
    - Amino acid composition
    - Physicochemical properties
    - Evolutionary information
  - Calculate structural features:
    - Contacts
    - Burial
    - Secondary structure
    - Solvent accessibility
- **EXECUTABLE OUTPUT:** Comprehensive feature vectors + feature importance assessment
- **NEXT STEP INPUT:** Train ML models

### STEP 2: ML Model Development
**ACTION:** Train multiple ML models for property prediction
- **INPUT SOURCE:** Feature vectors from Step 1 + experimental property labels
- **PROCESS:**
  - Train multiple architectures (random forest, XGBoost, neural networks)
  - Perform cross-validation
  - Optimize hyperparameters
  - Compare model performance
- **EXECUTABLE OUTPUT:** Trained ML models + performance metrics + feature importance rankings
- **NEXT STEP INPUT:** Predict properties of designed variants

### STEP 3: Property Prediction Pipeline
**ACTION:** Predict properties for protein design candidates
- **INPUT SOURCE:** Trained ML models from Step 2 + designed variants
- **PROCESS:**
  - Predict multiple properties (stability, expression, function, solubility)
  - Generate confidence scores
  - Quantify uncertainty
  - Ensemble predictions for robustness
- **EXECUTABLE OUTPUT:** Property predictions for variants + confidence intervals
- **NEXT STEP INPUT:** Optimize multi-property designs

### STEP 4: Design Optimization
**ACTION:** Multi-objective optimization to find best designs
- **INPUT SOURCE:** Property predictions from Step 3 + design constraints
- **PROCESS:**
  - Multi-objective optimization across properties
  - Identify Pareto frontier
  - Rank candidates for validation
  - Analyze trade-offs
- **EXECUTABLE OUTPUT:** ML-predicted protein designs + ranked candidate list
- **NEXT STEP INPUT:** Validate experimentally

### STEP 5: Validation and Model Refinement
**ACTION:** Validate predictions experimentally and improve models
- **INPUT SOURCE:** Experimental validation results
- **PROCESS:**
  - Compare predictions to measurements
  - Assess model accuracy
  - Identify prediction errors
  - Iteratively refine models
- **EXECUTABLE OUTPUT:** Refined ML models + validated design predictions + computational acceleration

---

## Workflow 4: Protein Evolution and Adaptive Landscapes

**Research Objective:** Understand protein evolution principles and predict evolutionary trajectories

### STEP 1: Evolutionary Relationship Mapping
**ACTION:** Construct evolutionary history and relationships
- **INPUT SOURCE:** Protein family sequence alignments + characterized phenotype data
- **PROCESS:**
  - Construct phylogenetic trees
  - Reconstruct ancestral sequences
  - Identify evolutionary divergence points
  - Analyze evolutionary rates
- **EXECUTABLE OUTPUT:** Evolutionary history + ancestral sequences + evolutionary distances
- **NEXT STEP INPUT:** Construct fitness landscape

### STEP 2: Fitness Landscape Construction
**ACTION:** Map adaptive landscape showing evolutionary pathways
- **INPUT SOURCE:** Evolutionary relationships from Step 1 + fitness data for modern variants
- **PROCESS:**
  - Compute pairwise sequence similarity
  - Interpolate fitness values
  - Visualize landscape
  - Identify fitness paths and maxima
- **EXECUTABLE OUTPUT:** Mapped adaptive landscape + fitness contours + evolutionary pathways
- **NEXT STEP INPUT:** Analyze evolutionary constraints

### STEP 3: Evolutionary Constraint and Innovation Analysis
**ACTION:** Identify conserved regions and positive selection sites
- **INPUT SOURCE:** Fitness landscape from Step 2 + sequence conservation data
- **PROCESS:**
  - Identify conserved residues and constraints
  - Detect positive selection sites (rapid adaptation)
  - Link mutations to functional innovations
  - Analyze covariation patterns
- **EXECUTABLE OUTPUT:** Characterized evolutionary patterns + positive selection signatures
- **NEXT STEP INPUT:** Build predictive evolution models

### STEP 4: Predictive Evolutionary Modeling
**ACTION:** Predict future evolutionary trajectories
- **INPUT SOURCE:** Evolutionary constraints from Step 3 + fitness landscape
- **PROCESS:**
  - Build ML models for evolution trajectory prediction
  - Predict functional innovations
  - Identify evolutionary dead-ends
  - Calculate fixation probabilities
- **EXECUTABLE OUTPUT:** Predictive evolution models + guided design principles
- **NEXT STEP INPUT:** Apply to design

### STEP 5: Evolution-Informed Design
**ACTION:** Design proteins using evolutionary principles
- **INPUT SOURCE:** Predictive models from Step 4 + design objectives
- **PROCESS:**
  - Design towards likely evolutionary paths
  - Avoid evolutionary dead-ends
  - Integrate with experimental evolution
  - Predict directed evolution outcomes
- **EXECUTABLE OUTPUT:** Evolutionarily-informed proteins with accelerated adaptation

---

## Workflow 5: Protein Rational Design Using Computational Methods

**Research Objective:** Develop computational methods for rational protein design with novel functions

### STEP 1: Computational Protein Design Framework
**ACTION:** Establish design framework and parameters
- **INPUT SOURCE:** Design objectives + target structure specs + constraints
- **PROCESS:**
  - Generate/select backbone conformations
  - Set up rotamer library for side-chains
  - Configure energy functions
  - Optimize score functions
- **EXECUTABLE OUTPUT:** Design framework specifications + parameter configurations
- **NEXT STEP INPUT:** Validate designs

### STEP 2: Design Validation
**ACTION:** Validate initial designed sequences
- **INPUT SOURCE:** Initial designed sequences from Step 1 + validation criteria
- **PROCESS:**
  - Predict structures (AlphaFold)
  - Assess folding stability
  - Validate function predictions
  - Score against target specs
- **EXECUTABLE OUTPUT:** Validated designer sequences + predicted structures and stabilities
- **NEXT STEP INPUT:** Refine designs iteratively

### STEP 3: Iterative Design Refinement
**ACTION:** Optimize designs through iterative refinement
- **INPUT SOURCE:** Validated sequences from Step 2 + refinement objectives
- **PROCESS:**
  - Explore design landscape
  - Add secondary mutations for enhancement
  - Multi-property optimization
  - Combinatorial exploration
- **EXECUTABLE OUTPUT:** Optimized design specifications + refined candidate sequences
- **NEXT STEP INPUT:** Plan experimental validation

### STEP 4: Experimental Design Integration
**ACTION:** Plan experimental validation
- **INPUT SOURCE:** Optimized designs from Step 3 + experimental plan
- **PROCESS:**
  - Design library for validation
  - Specify positive/negative controls
  - Design high-throughput screening
  - Plan data analysis
- **EXECUTABLE OUTPUT:** Complete experimental plan + library specifications
- **NEXT STEP INPUT:** Validate experimentally

### STEP 5: Design Validation and Iteration
**ACTION:** Validate computationally designed proteins experimentally
- **INPUT SOURCE:** Experimental results from wet lab
- **PROCESS:**
  - Validate computational predictions
  - Compare computational vs. actual performance
  - Iteratively refine based on results
  - Develop next-generation designs
- **EXECUTABLE OUTPUT:** Experimentally validated computationally designed proteins

---

# Regulation - Synthetic Regulatory Systems

## Workflow 1: Engineering Modular Biosensors for Metabolite-Responsive Regulation

**Research Objective:** Develop generalizable biosensors for metabolite-responsive transcription control

### STEP 1: Modular Component Selection
**ACTION:** Select compatible binding and DNA-binding proteins
- **INPUT SOURCE:** Target metabolite + ligand-binding protein database (e.g., MBP) + DNA-binding domain library
- **PROCESS:**
  - Screen ligand-binding proteins for specificity
  - Evaluate DNA-binding domain libraries
  - Assess component compatibility
  - Predict binding affinity
- **EXECUTABLE OUTPUT:** Selected modular components + compatibility scores
- **NEXT STEP INPUT:** Design fusion proteins

### STEP 2: Fusion Protein Design
**ACTION:** Design linker connecting biosensor components
- **INPUT SOURCE:** Selected components from Step 1 + linker specifications
- **PROCESS:**
  - Design linker sequences computationally
  - Screen linker variants
  - Model fusion conformations
  - Predict allosteric coupling efficiency
- **EXECUTABLE OUTPUT:** Library of MBP-ZFP fusion designs + coupling predictions
- **NEXT STEP INPUT:** Design synthetic promoters

### STEP 3: Synthetic Promoter Optimization
**ACTION:** Design promoter library with variable binding sites
- **INPUT SOURCE:** Biosensor constructs from Step 2 + desired output dynamics
- **PROCESS:**
  - Design variable operator sequences
  - Predict binding site strengths
  - Optimize activity levels
  - Predict kinetic parameters (KD, Vmax)
- **EXECUTABLE OUTPUT:** Paired biosensor-promoter designs + dose-response predictions
- **NEXT STEP INPUT:** Design high-throughput screening

### STEP 4: High-Throughput Screening Design
**ACTION:** Plan HTS to identify optimal biosensors
- **INPUT SOURCE:** Biosensor-promoter pairs from Step 3 + performance criteria
- **PROCESS:**
  - Specify library construction
  - Optimize screening methodology
  - Design data analysis pipeline
  - Plan statistical analysis
- **EXECUTABLE OUTPUT:** Validated metabolite biosensors with transferable design principles

---

## Workflow 2: Lanthanide-Controlled Protein Switches

**Research Objective:** Design metal-dependent allosteric protein switches for cellular control

### STEP 1: Coordination Site Identification
**ACTION:** Design lanthanide-binding sites in target protein
- **INPUT SOURCE:** Lanthanide metal ion specs (La, Ce, Eu, Tb, Dy) + protein framework
- **PROCESS:**
  - Computationally analyze lanthanide-binding pockets
  - Optimize coordination geometry
  - Design selectivity for specific lanthanides
- **EXECUTABLE OUTPUT:** Protein sequences with optimized coordination sites + selectivity predictions
- **NEXT STEP INPUT:** Optimize allosteric response

### STEP 2: Allosteric Mechanism Optimization
**ACTION:** Engineer conformational changes upon metal binding
- **INPUT SOURCE:** Protein designs from Step 1 + target output phenotype
- **PROCESS:**
  - Run MD simulations with/without lanthanide
  - Analyze conformational pathways
  - Calculate coupling efficiency
  - Predict free energy changes
- **EXECUTABLE OUTPUT:** Optimized lanthanide switches + conformational predictions
- **NEXT STEP INPUT:** Design cellular integration

### STEP 3: Cellular System Integration
**ACTION:** Design switches for in vivo cellular applications
- **INPUT SOURCE:** Optimized switches from Step 2 + cellular application specs
- **PROCESS:**
  - Model in vivo expression
  - Predict lanthanide availability and toxicity
  - Design signal transduction pathways
  - Integrate with regulatory networks
- **EXECUTABLE OUTPUT:** Cellular system integration specifications
- **NEXT STEP INPUT:** Design bioelectronic devices

### STEP 4: Bioelectronic Device Design
**ACTION:** Design switches for bioelectronic applications
- **INPUT SOURCE:** Validated cellular switches + electrochemical requirements
- **PROCESS:**
  - Design device interfaces
  - Specify signal transduction mechanisms
  - Predict electron transfer pathways
  - Model biocompatibility
- **EXECUTABLE OUTPUT:** Lanthanide switches for cellular and bioelectronic applications

---

## Workflow 3: Protein Design and Epistasis (Lipshitz et al.)

**Research Objective:** Account for epistasis in protein design for accurate predictions

### STEP 1: Epistasis Analysis
**ACTION:** Analyze nonadditive mutation interactions
- **INPUT SOURCE:** Multi-mutation fitness data + single mutation effects + structural context
- **PROCESS:**
  - Calculate epistatic interactions
  - Quantify deviations from additivity
  - Test statistical significance
  - Classify interaction types
- **EXECUTABLE OUTPUT:** Comprehensive epistasis map + interaction strengths
- **NEXT STEP INPUT:** Develop predictive models

### STEP 2: Predictive Modeling
**ACTION:** Build ML models incorporating epistasis
- **INPUT SOURCE:** Epistasis map from Step 1 + structural and evolutionary features
- **PROCESS:**
  - Train ML models on epistasis patterns
  - Integrate structural features (proximity, contact, conservation)
  - Cross-validate on independent data
  - Assess model performance
- **EXECUTABLE OUTPUT:** Epistasis-informed design models + improved predictions
- **NEXT STEP INPUT:** Optimize designs with epistasis

### STEP 3: Design Optimization with Epistasis
**ACTION:** Design protein variants accounting for epistatic interactions
- **INPUT SOURCE:** Predictive models from Step 2 + protein function specs
- **PROCESS:**
  - Multi-objective optimization with epistasis
  - Identify synergistic mutation combinations
  - Avoid deleterious interactions
  - Rank variants with epistasis consideration
- **EXECUTABLE OUTPUT:** Improved protein variants with epistasis-aware predictions

---

## Workflow 4: Synthetic Regulatory Circuits

**Research Objective:** Engineer programmable gene circuits with predictable behavior

### STEP 1: Circuit Modeling
**ACTION:** Model gene circuit dynamics with ODEs
- **INPUT SOURCE:** Circuit topology specs + desired logic functions (AND, OR, NOT)
- **PROCESS:**
  - Develop Ordinary Differential Equations (ODE)
  - Optimize circuit parameters
  - Predict steady-state behavior
  - Perform sensitivity analysis
- **EXECUTABLE OUTPUT:** Optimized circuit parameters + output predictions + transfer functions
- **NEXT STEP INPUT:** Select genetic components

### STEP 2: Genetic Component Selection
**ACTION:** Choose promoters and RBS for circuit components
- **INPUT SOURCE:** Circuit parameters from Step 1 + genetic parts library
- **PROCESS:**
  - Predict promoter strengths
  - Calculate RBS strengths
  - Optimize expression levels
  - Analyze component compatibility
- **EXECUTABLE OUTPUT:** Genetic parts specifications + optimized expression levels
- **NEXT STEP INPUT:** Predict expression in cells

### STEP 3: Construction and Expression Prediction
**ACTION:** Predict circuit behavior in cellular context
- **INPUT SOURCE:** Genetic parts from Step 2 + target cellular host
- **PROCESS:**
  - Predict actual circuit behavior in cells
  - Model protein kinetics
  - Assess metabolic burden
  - Predict temporal dynamics
- **EXECUTABLE OUTPUT:** Characterized synthetic circuits with predictable logic and dynamics

---

## Workflow 5: Transcription Factor Networks

**Research Objective:** Map and model comprehensive gene regulatory networks

### STEP 1: Network Inference
**ACTION:** Infer transcription factor-target gene networks
- **INPUT SOURCE:** Genomic sequences + ChIP-seq or RNA-seq data + TF binding motifs
- **PROCESS:**
  - Identify TF binding sites
  - Analyze co-regulation patterns
  - Associate TF binding with gene expression
  - Assess network edge significance
- **EXECUTABLE OUTPUT:** Predicted TF-target networks + confidence scores + direct vs. indirect interactions
- **NEXT STEP INPUT:** Analyze network architecture

### STEP 2: Network Analysis
**ACTION:** Characterize regulatory network topology and modules
- **INPUT SOURCE:** TF-target networks from Step 1 + gene expression and annotation data
- **PROCESS:**
  - Discover regulatory motifs
  - Identify regulatory modules
  - Detect feedback loops
  - Identify network hubs and bottlenecks
- **EXECUTABLE OUTPUT:** Characterized regulatory architecture + modules + feedback specifications
- **NEXT STEP INPUT:** Develop mechanistic models

### STEP 3: Mechanistic Modeling
**ACTION:** Build ODE models of transcriptional regulation
- **INPUT SOURCE:** Network architecture from Step 2 + gene expression measurements
- **PROCESS:**
  - Model transcriptional dynamics with ODEs
  - Integrate multiple regulatory inputs
  - Predict cellular behavior under perturbations
  - Analyze network robustness
- **EXECUTABLE OUTPUT:** Comprehensive regulatory network models with predictive power
- **NEXT STEP INPUT:** Extract design principles

### STEP 4: Design Principles and Validation
**ACTION:** Extract generalizable regulatory design principles
- **INPUT SOURCE:** Mechanistic models from Step 3 + target phenotype/behavior specs
- **PROCESS:**
  - Extract design principles
  - Predict regulatory changes for new behavior
  - Simulate network perturbations
  - Design synthetic circuits based on principles
- **EXECUTABLE OUTPUT:** Design principles for regulatory engineering + validated for implementation

---

# RiPP - Ribosomally Synthesized Peptides

## Workflow 1: Discovery and Engineering of RiPP Natural Products

**Research Objective:** Systematically discover and activate RiPP natural products from silent clusters

### STEP 1: RiPP Bioactivity-Guided Screening
**ACTION:** Identify bioactive RiPPs from environmental samples
- **INPUT SOURCE:** Microbial samples from diverse environments + bioactivity screening data
- **PROCESS:**
  - Analyze high-throughput screening data (HiTES)
  - Process LAESI-IMS mass spectrometry data
  - Perform MS-based dereplication
  - Identify novel bioactive molecules
- **EXECUTABLE OUTPUT:** Identified bioactive RiPP candidates + chemical characterization + source organisms
- **NEXT STEP INPUT:** Mine genomes for RiPP BGCs

### STEP 2: RiPP Genome Mining
**ACTION:** Identify BGCs corresponding to bioactive RiPPs
- **INPUT SOURCE:** Bioactive RiPPs from Step 1 + genomic sequences from bioactive sources
- **PROCESS:**
  - Identify precursor peptide sequences (BLAST, ML tools)
  - Detect PTM enzymes using RODEO, RiPPER, RRE-Finder
  - Predict BGC boundaries
  - Assign RiPP class
- **EXECUTABLE OUTPUT:** Computationally identified RiPP BGCs + PTM enzyme characterization + precursor sequences
- **NEXT STEP INPUT:** Design BGC activation strategy

### STEP 3: Silent RiPP Activation Design
**ACTION:** Design system for producing RiPPs from silent BGCs
- **INPUT SOURCE:** Characterized RiPP BGCs from Step 2 + known expression strategies
- **PROCESS:**
  - Design BGC expression constructs
  - Engineer regulatory elements
  - Select heterologous hosts
  - Optimize activation signals
- **EXECUTABLE OUTPUT:** Expression system specifications + optimized construct designs
- **NEXT STEP INPUT:** Optimize biosynthetic production

### STEP 4: Biosynthetic Engineering and PTM Optimization
**ACTION:** Optimize RiPP production and post-translational modifications
- **INPUT SOURCE:** RiPP expression systems from Step 3 + PTM pathway information
- **PROCESS:**
  - Engineer precursor peptides
  - Optimize enzyme expression levels
  - Engineer PTM pathways
  - Optimize yields
- **EXECUTABLE OUTPUT:** Engineered RiPP production system with optimized yields

---

## Workflow 2: Lasso Peptides as Antimicrobial Agents

**Research Objective:** Develop lasso peptides as next-generation antibiotics

### STEP 1: Lasso Peptide Structure Classification
**ACTION:** Classify lasso peptides by structural architecture
- **INPUT SOURCE:** Known lasso sequences (50+) + predicted sequences (thousands) + resistance gene data
- **PROCESS:**
  - Analyze macrolactam ring architecture
  - Classify into lasso classes (I-V)
  - Predict disulfide bond patterns
  - Analyze ring topology
- **EXECUTABLE OUTPUT:** Structurally characterized lasso peptide database + feature annotations
- **NEXT STEP INPUT:** Analyze structure-activity relationships

### STEP 2: Structure-Activity Relationship (SAR) Analysis
**ACTION:** Link structural features to antimicrobial properties
- **INPUT SOURCE:** Classified lassos from Step 1 + experimental bioactivity data + structural database
- **PROCESS:**
  - Correlate structural features with activity
  - Identify functionally critical residues
  - Predict thermal and proteolytic stability
  - Develop ML SAR models
  - Predict binding modes
- **EXECUTABLE OUTPUT:** SAR models linking structure to bioactivity + critical residue identification
- **NEXT STEP INPUT:** Predict mechanism of action

### STEP 3: Mechanism of Action Prediction
**ACTION:** Predict how lasso peptides kill drug-resistant bacteria
- **INPUT SOURCE:** SAR models from Step 2 + target bacterial genome information
- **PROCESS:**
  - Predict molecular targets
  - Perform molecular docking
  - Predict binding specificity
  - Predict off-targets
- **EXECUTABLE OUTPUT:** Predicted mechanisms against MDR bacteria + target selectivity assessment
- **NEXT STEP INPUT:** Optimize therapeutic design

### STEP 4: Therapeutic Lasso Design Optimization
**ACTION:** Engineer lasso peptides with improved clinical properties
- **INPUT SOURCE:** Mechanism predictions from Step 3 + therapeutic design constraints
- **PROCESS:**
  - Design lasso variants with improved specificity
  - Predict improved stability/bioavailability
  - Consider synthesis feasibility
  - Predict resistance potential
- **EXECUTABLE OUTPUT:** Optimized lasso peptide designs for clinical development

---

## Workflow 3: RiPP PTM Diversity and Ecological Roles

**Research Objective:** Understand ecological significance of RiPP post-translational modifications

### STEP 1: PTM Enzyme Classification
**ACTION:** Classify post-translational modification enzymes
- **INPUT SOURCE:** RiPP BGC database + PTM enzyme sequences + structural information
- **PROCESS:**
  - Analyze PTM enzyme sequences and domains
  - Cluster homologous enzymes
  - Classify into PTM types (cyclization, oxidation, glycosylation, etc.)
  - Annotate functions
- **EXECUTABLE OUTPUT:** Classified PTM enzyme catalog + functional assignments + enzyme relationships
- **NEXT STEP INPUT:** Map PTM patterns

### STEP 2: PTM Modification Pattern Analysis
**ACTION:** Analyze patterns of post-translational modifications
- **INPUT SOURCE:** Classified PTM enzymes from Step 1 + RiPP sequences and structures
- **PROCESS:**
  - Analyze modification patterns in core peptides
  - Correlate PTM types with RiPP class
  - Identify functionally important modification positions
  - Analyze modification frequencies
- **EXECUTABLE OUTPUT:** PTM modification pattern map + structure-pattern correlations
- **NEXT STEP INPUT:** Analyze ecological context

### STEP 3: Ecological Niche Analysis
**ACTION:** Determine environmental contexts where RiPPs are produced
- **INPUT SOURCE:** PTM patterns from Step 2 + ecological and environmental metadata
- **PROCESS:**
  - Correlate RiPP types with environmental conditions
  - Analyze co-occurring BGCs (synteny)
  - Predict metabolic coupling
  - Predict competitive advantages
- **EXECUTABLE OUTPUT:** Ecological context of RiPP PTMs + environmental preference patterns
- **NEXT STEP INPUT:** Predict functions

### STEP 4: Functional Prediction from PTM Profile
**ACTION:** Predict RiPP functions based on PTM profiles
- **INPUT SOURCE:** Ecological context from Step 3 + RiPP BGC characterization
- **PROCESS:**
  - Predict bioactivity types
  - Predict target pathways
  - Assess therapeutic potential
  - Analyze evolutionary constraints
- **EXECUTABLE OUTPUT:** Ecological and functional understanding of RiPP diversity + prioritized RiPPs

---

## Workflow 4: RiPP-Phage Interactions in Ocean Microbiota

**Research Objective:** Understand RiPP-phage predator-prey interactions in marine ecosystems

### STEP 1: Marine RiPP BGC Identification
**ACTION:** Mine marine microbiomes for RiPP BGCs
- **INPUT SOURCE:** Marine metagenomic sequences + oceanographic metadata + RiPP signatures
- **PROCESS:**
  - Mine metagenomic sequences for RiPP BGCs
  - Analyze environmental distribution
  - Correlate abundance with oceanographic parameters
  - Map biogeographic patterns
- **EXECUTABLE OUTPUT:** Characterized marine RiPP producers + environmental distribution maps
- **NEXT STEP INPUT:** Analyze phage interactions

### STEP 2: Phage-BGC Interaction Prediction
**ACTION:** Predict RiPP defense functions against phages
- **INPUT SOURCE:** Marine RiPPs from Step 1 + marine phage genome data + CRISPR arrays
- **PROCESS:**
  - Analyze CRISPR-Cas systems
  - Predict RiPP immunity functions
  - Model phage resistance mechanisms
  - Predict host-phage compatibility
- **EXECUTABLE OUTPUT:** Predicted phage-RiPP interactions + defense mechanism specifications
- **NEXT STEP INPUT:** Analyze evolutionary arms race

### STEP 3: Arms Race Evolutionary Analysis
**ACTION:** Characterize evolutionary adaptation in RiPP-phage interactions
- **INPUT SOURCE:** RiPP-phage interactions from Step 2 + evolutionary sequence data
- **PROCESS:**
  - Compare RiPP variants and phage countermeasures
  - Identify evolutionary hotspots
  - Track phylogenetic adaptation
  - Detect coevolution signals
- **EXECUTABLE OUTPUT:** Understanding of ecological dynamics + evolutionary constraints
- **NEXT STEP INPUT:** Assess ecosystem impact

### STEP 4: Functional Diversity and Ecosystem Impact
**ACTION:** Determine ecosystem-level importance of RiPP-phage interactions
- **INPUT SOURCE:** Evolutionary understanding from Step 3 + ecological community data
- **PROCESS:**
  - Assess RiPP role in marine ecosystems
  - Predict community structure impacts
  - Model population dynamics
  - Determine biogeochemical significance
- **EXECUTABLE OUTPUT:** Marine RiPP ecology model + ecosystem-level understanding

---

## Workflow 5: Ecological Roles of RiPPs in Microbial Communities

**Research Objective:** Determine ecological functions and community impacts of RiPP production

### STEP 1: RiPP Producer Abundance Correlation
**ACTION:** Analyze when and where RiPP producers are abundant
- **INPUT SOURCE:** Microbiota composition data + RiPP BGC presence/absence + metabolomic data + environmental parameters
- **PROCESS:**
  - Analyze RiPP producer prevalence across environments
  - Correlate with community richness and stability
  - Identify selective pressures favoring RiPP production
  - Analyze co-occurrence patterns
- **EXECUTABLE OUTPUT:** Ecological niches for RiPP production + community role determination
- **NEXT STEP INPUT:** Model community dynamics

### STEP 2: Community-Scale Modeling
**ACTION:** Model multi-species interactions including RiPP-mediated effects
- **INPUT SOURCE:** Ecological niches from Step 1 + RiPP effects on other organisms
- **PROCESS:**
  - Model multi-species interactions
  - Simulate RiPP-mediated competition and cooperation
  - Predict community assembly rules
  - Model metabolite diffusion
- **EXECUTABLE OUTPUT:** Predictive community models + dynamics simulations
- **NEXT STEP INPUT:** Predict RiPP functions

### STEP 3: Functional Prediction of RiPP Roles
**ACTION:** Predict specific ecological functions of RiPPs
- **INPUT SOURCE:** Community models from Step 2 + RiPP BGC characterization
- **PROCESS:**
  - Identify target organisms
  - Predict antimicrobial selectivity
  - Predict nutrient cycling impacts
  - Predict resource competition effects
- **EXECUTABLE OUTPUT:** Mechanistic understanding of RiPP ecological roles
- **NEXT STEP INPUT:** Design microbiota engineering

### STEP 4: Community Engineering Applications
**ACTION:** Design principles for microbiota manipulation
- **INPUT SOURCE:** Functional understanding from Step 3 + target community modification goals
- **PROCESS:**
  - Extract design principles for microbiota manipulation
  - Optimize RiPP production strategies
  - Predict dysbiosis reversal approaches
  - Assess therapeutic potential
- **EXECUTABLE OUTPUT:** Microbiota engineering framework + design principles for therapeutic applications

---

## Summary: Experimental Design Implementation

Each workflow follows a sequential pipeline where outputs become inputs for the next step. To implement these workflows:

1. **Start at Step 1** - Begin with raw input data as specified
2. **Execute computational analysis** - Process data using specified tools and methods
3. **Generate intermediate outputs** - Create deliverables that feed into the next step
4. **Progress through steps** - Each step builds on previous results
5. **Reach final product** - Arrive at experimentally validated systems or compounds

### Key Design Principles:

- **Data continuity**: Output of step N = Input of step N+1
- **Executable actions**: Each step has clear, actionable computational procedures
- **Tool specification**: Relevant software and algorithms are identified at each step
- **Iterative refinement**: Results can be fed back to improve designs
- **Multi-scale integration**: From molecular design to ecosystem-level effects

These workflows provide a comprehensive blueprint for designing and executing computational biology experiments across multiple research domains.
